immune-mediated necrotizing myopathy
ORPHA: 206569
Overview
human muscle disease
Available Treatments (0)
No treatments linked yet
Clinical trials or compassionate use may be available — consult a specialist.
Clinical Presentation
Signs and symptoms associated with immune-mediated necrotizing myopathy, sourced from HPO and Orphanet clinical annotations.
MyopathyElevated circulating creatine kinase concentrationEMG: myopathic abnormalitiesMuscle fiber necrosisAutoimmune antibody positivityFatiguable weakness of proximal limb musclesDysphagiaSkeletal muscle atrophyMyalgiaProximal lower limb muscle weaknessAnti-3-hydroxy- 3-methylglutaryl-coA reductase antibody positivityAnti-signal recognition particle antibody positivityMyositisPalpitationsNeoplasmAxial muscle weaknessScapular wingingAbnormal pulmonary interstitial morphologyMyocarditisChest painSkin rashCongestive heart failureArthralgiaRaynaud phenomenon
Classification & Codes
Orphanet Code
ORPHA:206569immune-mediated necrotizing myopathy
| Orphanet | ORPHA:206569 |
| Treatments | 0 drug(s) |
| Symptoms on record | 24 signs |
| Status | published |
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO